Literature DB >> 26886797

Autoimmunity: Antigen-specific immunotherapy.

David Wraith1.   

Abstract

Mesh：

Substances：

Year:  2016        PMID： 26886797     DOI： 10.1038/nature17300

Source DB:  PubMed          Journal:  Nature        ISSN： 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  10 in total

Review 1.  T cell anergy.

Authors:  Ronald H Schwartz
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

Review 2.  Activation rules: the two-signal theories of immune activation.

Authors:  Alan G Baxter; Philip D Hodgkin
Journal:  Nat Rev Immunol       Date:  2002-06       Impact factor: 53.106

Review 3.  IL-10-producing and naturally occurring CD4+ Tregs: limiting collateral damage.

Authors:  Anne O'Garra; Pedro L Vieira; Paulo Vieira; Anne E Goldfeld
Journal:  J Clin Invest       Date:  2004-11       Impact factor: 14.808

4.  A new analysis of allogeneic interactions.

Authors:  K J Lafferty; A J Cunningham
Journal:  Aust J Exp Biol Med Sci       Date:  1975-02

Review 5.  Peptide-based therapeutic vaccines for allergic and autoimmune diseases.

Authors:  Mark Larché; David C Wraith
Journal:  Nat Med       Date:  2005-04       Impact factor: 53.440

Review 6.  Antigen-specific immunotherapy of autoimmune and allergic diseases.

Authors:  Catherine A Sabatos-Peyton; Johan Verhagen; David C Wraith
Journal:  Curr Opin Immunol       Date:  2010-09-17       Impact factor: 7.486

7.  Expanding antigen-specific regulatory networks to treat autoimmunity.

Authors:  Xavier Clemente-Casares; Jesus Blanco; Poornima Ambalavanan; Jun Yamanouchi; Santiswarup Singha; Cesar Fandos; Sue Tsai; Jinguo Wang; Nahir Garabatos; Cristina Izquierdo; Smriti Agrawal; Michael B Keough; V Wee Yong; Eddie James; Anna Moore; Yang Yang; Thomas Stratmann; Pau Serra; Pere Santamaria
Journal:  Nature       Date:  2016-02-17       Impact factor: 49.962

8.  Interleukin-10 production by effector T cells: Th1 cells show self control.

Authors:  Giorgio Trinchieri
Journal:  J Exp Med       Date:  2007-02-12       Impact factor: 14.307

9.  Sequential transcriptional changes dictate safe and effective antigen-specific immunotherapy.

Authors:  Bronwen R Burton; Graham J Britton; Hai Fang; Johan Verhagen; Ben Smithers; Catherine A Sabatos-Peyton; Laura J Carney; Julian Gough; Stephan Strobel; David C Wraith
Journal:  Nat Commun       Date:  2014-09-03       Impact factor: 14.919

10.  Negative feedback control of the autoimmune response through antigen-induced differentiation of IL-10-secreting Th1 cells.

Authors:  Leona Gabrysová; Kirsty S Nicolson; Heather B Streeter; Johan Verhagen; Catherine A Sabatos-Peyton; David J Morgan; David C Wraith
Journal:  J Exp Med       Date:  2009-07-27       Impact factor: 14.307
  10 in total
  10 in total

1.  Quantifying immunoregulation by autoantigen-specific T-regulatory type 1 cells in mice with simultaneous hepatic and extra-hepatic autoimmune disorders.

Authors:  Hassan Jamaleddine; Pere Santamaria; Anmar Khadra
Journal:  Immunology       Date:  2020-09-11       Impact factor: 7.397

Review 2.  Unmet challenges in membranous nephropathy.

Authors:  David J Salant
Journal:  Curr Opin Nephrol Hypertens       Date:  2019-01       Impact factor: 2.894

3.  Identification of four novel T cell autoantigens and personal autoreactive profiles in multiple sclerosis.

Authors:  Mattias Bronge; Klara Asplund Högelin; Olivia G Thomas; Sabrina Ruhrmann; Claudia Carvalho-Queiroz; Ola B Nilsson; Andreas Kaiser; Manuel Zeitelhofer; Erik Holmgren; Mathias Linnerbauer; Milena Z Adzemovic; Cecilia Hellström; Ivan Jelcic; Hao Liu; Peter Nilsson; Jan Hillert; Lou Brundin; Katharina Fink; Ingrid Kockum; Katarina Tengvall; Roland Martin; Hanna Tegel; Torbjörn Gräslund; Faiez Al Nimer; André Ortlieb Guerreiro-Cacais; Mohsen Khademi; Guro Gafvelin; Tomas Olsson; Hans Grönlund
Journal:  Sci Adv       Date:  2022-04-27       Impact factor: 14.957

4.  The Future of Immunotherapy: A 20-Year Perspective.

Authors:  David C Wraith
Journal:  Front Immunol       Date:  2017-11-28       Impact factor: 7.561

5.  Chromatin Priming Renders T Cell Tolerance-Associated Genes Sensitive to Activation below the Signaling Threshold for Immune Response Genes.

Authors:  Sarah L Bevington; Sky T H Ng; Graham J Britton; Peter Keane; David C Wraith; Peter N Cockerill
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

Review 6.  How Times Have Changed! A Cornucopia of Antigens for Membranous Nephropathy.

Authors:  Tiffany N Caza; Laith F Al-Rabadi; Laurence H Beck
Journal:  Front Immunol       Date:  2021-11-26       Impact factor: 7.561

7.  A Sensitive Whole Blood Assay Detects Antigen-Stimulated Cytokine Release From CD4+ T Cells and Facilitates Immunomonitoring in a Phase 2 Clinical Trial of Nexvax2 in Coeliac Disease.

Authors:  Melinda Y Hardy; Gautam Goel; Amy K Russell; Swee Lin G Chen Yi Mei; Gregor J E Brown; Suyue Wang; Evan Szymczak; Ruan Zhang; Kaela E Goldstein; Kristin M Neff; Leslie J Williams; Kenneth E Truitt; John L Dzuris; Jason A Tye-Din; Robert P Anderson
Journal:  Front Immunol       Date:  2021-05-19       Impact factor: 7.561

Review 8.  Review of Mouse Models of Graves' Disease and Orbitopathy-Novel Treatment by Induction of Tolerance.

Authors:  Martin Ungerer; Julia Faßbender; Zhongmin Li; Götz Münch; Hans-Peter Holthoff
Journal:  Clin Rev Allergy Immunol       Date:  2017-04       Impact factor: 8.667

Review 9.  Antigen-Specific Immunotherapy for Treatment of Autoimmune Liver Diseases.

Authors:  Naomi Richardson; Sky T H Ng; David C Wraith
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561

Review 10.  The Emerging Jamboree of Transformative Therapies for Autoimmune Diseases.

Authors:  José M Carballido; Camille Regairaz; Celine Rauld; Layla Raad; Damien Picard; Michael Kammüller
Journal:  Front Immunol       Date:  2020-03-31       Impact factor: 7.561
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.